Policy & Regulation
19 July 2019 - - German drugmaker Boehringer Ingelheim and South Korea-based Bridge Biotherapeutics Inc. are entering into a new collaboration and license agreement with the goal of developing Br...
19 July 2019 - - Irish small molecule therapeutics developer Inflection Biosciences (Inflection) and Singapore-based AUM Biosciences, a company focused on the development of innovative and affordable ...
19 July 2019 - - Leslie L. Dan has retired from US-based fusion protein therapeutics developer Sesen Bio's (NASDAQ: SESN) board of directors, the company said.
With the retirement of ...
19 July 2019 - - US-based biopharmaceutical company Cortexyme, Inc. (NASDAQ: CRTX) has presented clinical data that supports its ongoing work to pioneer a novel, disease-modifying therapeutic approach...
19 July 2019 - - German drugmaker Bayer, US-based Bristol-Myers Squibb Company (NYSE: BMY) and Japan-based Ono Pharmaceutical Co., Ltd. have entered into a clinical collaboration agreement to eva...
19 July 2019 - Critical care medicine company Pharmazz Inc said on Thursday that it has received clearance to launch a prospective, multicentric, randomized, double-blind, parallel, phase III clinical...
Related Headlines